GENE ONLINE|News &
Opinion
Blog

Tislelizumab
BeiGene
BeiGene Granted NMPA Approval to Treat World’s Most Prevalent Esophageal Cancer
2022-04-20
BeiGene
EMA Begins Review of BeiGene, Novartis’s PD-1 Antibody for Esophageal and Lung Cancer
2022-04-13
Immuno-oncologyNovartis
Novartis Licenses BeiGene’s Antibody for a Potential $2.8 Billion After Its Own Drug Disappoints
2021-12-21
Trials & Approvals Tislelizumab
FDA Accepts BeiGene’s BLA for Esophageal Cancer Drug
2021-09-14
Trials & Approvals Immunotherapy
Chinese Regulator Accepts BeiGene’s Tislelizumab sBLA for Nasopharyngeal Cancer
2021-08-23
Cancer
Novartis Fortifies Immuno-Oncology Franchise with BeiGene Collaboration
2021-01-15
Biotech Duo Revise Co-development & Commercialization Agreement of Intelligent Drug Delivery System
2020-10-08
LATEST
Unity Technologies Announces Unity 7 Development Roadmap at Unite Seoul
2026-07-20
Road Traffic Injuries Caused 1.34 Million Deaths and 51 Million Injuries Globally in 2023
2026-07-20
Ross Stores Expands to 2,150 Locations With 47 New Openings
2026-07-20
SRMMF Issues Formal Statement Clarifying Performance Rights Status on July 20, 2026
2026-07-20
Study Finds Collagen Peptide Supplementation May Support Bone Health in Female Runners
2026-07-20
Aspire Biopharma Signs X Games Medalist Jarryd McNeil to Promote BUZZ BOMB Line
2026-07-20
Pipistrel Introduces Voyager Aircraft With Digital Avionics for Flight Training
2026-07-20
READ MORE
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
SEE MORE
Scroll to Top